31.08.2016 09:00:31
|
Arbitrator appointed for the redemption proceedings concerning Okmetic's minority shares
OKMETIC OYJ STOCK EXCHANGE RELEASE 31 AUGUST 2016 AT 10.00 A.M.
NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER OR SUCH RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW OR REQUIRE OFFER DOCUMENTS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER FINNISH LAW.
ARBITRATOR APPOINTED FOR THE REDEMPTION PROCEEDINGS CONCERNING OKMETIC'S MINORITY SHARES
The Redemption Committee of the Finland Chamber of Commerce has appointed an arbitral tribunal consisting of one arbitrator for the redemption proceedings concerning the redemption of Okmetic Oyj's ("Okmetic") shares not held by NSIG Finland S.à r.l. ("NSIG Finland"). The arbitral tribunal comprises Professor Kari Hoppu.
Okmetic announced on 23 June 2016 that NSIG Finland will initiate arbitration proceedings as provided in the Finnish Limited Liability Companies Act to effectuate the redemption of all remaining Okmetic shares held by minority shareholders. In addition, Okmetic announced on 13 July 2016 that the District Court of Vantaa appointed with its decision M.Sc. (Econ.) Camilla Viherlaakso to act as the trustee in the arbitration proceedings.
OKMETIC OYJ
Kai Seikku
President
For further information, please contact:
Kai Seikku, President
Tel. +358 9 5028 0232, e-mail: kai.seikku@okmetic.com
Okmetic supplies tailored, high value-added silicon wafers to be used in the manufacture of sensors as well as discrete semiconductors and analog circuits. Okmetic's strategic objective is profitable growth driven by a product portfolio designed to meet customers' current and future technology needs. The core of the company's operations is being genuinely close to the customers and understanding their needs and processes.
Okmetic's global sales network, extensive portfolio of high value-added products, in-depth knowledge of crystal growing, long-term product development projects, as well as efficient and flexible production create prerequisites for achieving the strategic targets. The company's headquarters is located in Finland, where the majority of the company's silicon wafers is manufactured. In addition to in-house manufacture, Okmetic has contract manufacturing in Japan and China. Okmetic's shares are listed on Nasdaq Helsinki Ltd under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com.
NSIG is a limited liability company organized under the PRC laws. The registered office of NSIG is in Shanghai, China.
Established in 2015, NSIG is a China-based holding group that is engaged in the investment and development of semiconductor materials and equipment industry with a registered capital of RMB 2 billion (approximately EUR 272 million). NSIG's mission is to establish a major industrial player in the global semiconductor sector (especially silicon and its ecosystems) through both PRC domestic investments and outbound mergers and acquisitions.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Okmetic Oyj via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Okmetic OyjShsmehr Nachrichten
Keine Nachrichten verfügbar. |